OUR AMBITION

StromaCare is a pioneer biotech company in the field of Tumoral Stroma biology and role in multiple solid cancers.

StromaCare scientific Team has developed a deep expertise in identifying and understanding tumoral stroma components playing a key role in cancer, as demonstrated by several publications in major international scientific reviews.

StromaCare’s ambition is to develop innovative products in immuno-oncology to :

- Address specifically stromal components promoting tumor growth, immune escape and metastasis

- Modulate the stroma structure to enhance delivery of therapeutic agents at the core of the tumor and facilitate tumor resection surgery.

StromaCare is set to advance its first lead product to a First-in-Human clinical trial targeting multiple cancer types.